Art
J-GLOBAL ID:201802249285026220   Reference number:18A0504058

Intrinsic insulin secretion capacity might be preserved by discontinuing anti-programmed cell death protein 1 antibody treatment in ‘anti-programmed cell death protein 1 antibody-induced’ fulminant type 1 diabetes

「抗プログラム細胞死蛋白質1抗体が誘導する」劇症1型糖尿病では抗プログラム細胞死蛋白質1抗体による治療を中止することで内因性インスリン分泌能力が保存される可能性がある
Author (10):
Material:
Volume:Issue:Page: 448-449  Publication year: 2018 
JST Material Number: U0507A  ISSN: 2040-1124  Document type: Article
Article type: 短報  Country of issue: United States (USA)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0504058&from=J-GLOBAL&jstjournalNo=U0507A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Clinical application of antitumor(=antineoplastic)drugs  ,  Metabolic diseases,nutritional diseases in general.  ,  Drug therapy(=pharmacotherapy)for tumors 

Return to Previous Page